Abstract Aims Acute surgical patients have a significant risk of venous thromboembolism (VTE) due to factors such as surgery, immobility, dehydration, and existing comorbidities. All admitted an acute unit should their VTE assessed. Our aim was assess prophylaxis practices. Methods We performed closed loop audit on DVT using the Scottish Intercollegiate Guidelines Network proforma. Data anti-em...

Abstract Aim VTE prophylaxis is a vital aspect of patient safety. The decision whether to offer pharmacological thromboprophylaxis balance risk versus benefit. There low incidence in ENT patients, admissions are often short and active bleeding on admission not uncommon (epistaxis already anticoagulation particularly difficult manage}. no clear, specialty specific guidelines assist these frequen...

Venous thromboembolism is a well-known complication of total knee replacement, total hip replacement, and hip fracture repair. Venous thromboembolism, which includes deep vein thrombosis and pulmonary embolism, can cause significant morbidity and mortality. In addition, treatment of this condition can result in substantial costs to the health care system. Patients who have undergone orthopedic ...

A strong evidence base exists supporting thromboprophylaxis for venous thromboembolism (VTE) in surgical patients. Given the ageing population, obesity epidemic, and rise in type 2 diabetes, VTE and peripheral vascular disease (PAD) are likely to become an escalating problem. PAD is a contraindication to the use of anti-embolism stockings (AES). Half of those patients diagnosed with PAD report ...

The recently published American Association of Orthopedic Surgeons (AAOS) guidelines for the prevention of venous thromboembolism (VTE) in patients undergoing hip or knee surgery conflict with long-established and widely used American College of Chest Physicians (ACCP) guidelines. Both guidelines accepted that the most important goal of thromboprophylaxis in patients undergoing hip or knee repl...

Dabigatran etexilate was recently approved by the Therapeutic Goods Administration for thromboprophylactic use in adults undergoing elective total hip or knee replacement. Dabigatran etexilate is the prodrug of the active moiety dabigatran, an orally active agent that could replace enoxaparin in some clinical indications. Dabigatran is a direct thrombin inhibitor; it has stable, predictable pha...

Symptomatic venous thromboembolism (VTE) occurs 4-7 times more frequently in cancer patients as compared to non-cancer patients. A significant number of risk factors, which can be subcategorised as patient-, cancer- or treatment-related, have been shown to influence the risk of VTE during malignancy and further incorporated in risk-assessment models. Safe and efficient thromboprophylaxis regime...

OBJECTIVE Venous thromboembolism (VTE) is major problem after hip fracture surgery with substantial morbidity and mortality. This study aimed to assess the postoperative compliance of thromboprophylaxis in elderly patients undergoing hip fracture surgery and to confirm the correlation between compliance and VTE risk. METHODS This retrospective cohort study included consecutive elderly hip fra...

Abstract Introduction The Fontan circulation is associated with an increased risk of thromboembolic events. However, the optimal strategy for thromboprophylaxis in this population remains unknown. Purpose aim study was to compare efficacy and safety aspirin, warfarin, non-vitamin K antagonist oral anticoagulants (NOACs) a network meta-analysis using no as common comparator. Methods A comprehens...

BACKGROUND Venous thromboembolic disease (TED), although very rare, is a major cause of maternal mortality and morbidity, hence methods of prophylaxis are often used for women at risk. This may include women delivered by caesarean section, those with a personal or family history of TED and women with inherited or acquired thrombophilias (conditions that predispose people to thrombosis). Many me...